These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacokinetic profile of a new 3-azinomethyl rifamycin (SPA-S-565) in volunteers as compared with conventional rifampicin. Kelkar MS; Saraf AP; Bakhle DS; Nazare V; Ajay S; Hegde S; Lal HM; Cooverji ND; Bruzzese T Int J Clin Pharmacol Res; 1998; 18(3):137-43. PubMed ID: 9825270 [TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical study of suppository formulations for improved in vivo kinetics of rifampicin. Taki H; Ogawa K; Nikai T Kekkaku; 2008 Jun; 83(6):451-6. PubMed ID: 18634449 [TBL] [Abstract][Full Text] [Related]
5. Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety. Singh H; Jindal S; Singh M; Sharma G; Kaur IP Int J Pharm; 2015 May; 485(1-2):138-51. PubMed ID: 25769294 [TBL] [Abstract][Full Text] [Related]
6. Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global market. Pillai G; Fourie PB; Padayatchi N; Onyebujoh PC; McIlleron H; Smith PJ; Gabriels G Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S309-16; discussion S317-21. PubMed ID: 10593710 [TBL] [Abstract][Full Text] [Related]
7. Rifampicin pharmacokinetics with and without ciprofloxacin. Orisakwe OE; Agbasi PU; Afonne OJ; Ofoefule SI; Obi E; Orish CN Am J Ther; 2001; 8(3):151-3. PubMed ID: 11344382 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients. Yunivita V; Dian S; Ganiem AR; Hayati E; Hanggono Achmad T; Purnama Dewi A; Teulen M; Meijerhof-Jager P; van Crevel R; Aarnoutse R; Ruslami R Int J Antimicrob Agents; 2016 Oct; 48(4):415-21. PubMed ID: 27526979 [TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection]. Taki H; Ogawa K; Nakagawa T; Kashima K; Tarumi O; Saitou Y; Yamada N; Tano M; Nikai T Kekkaku; 2007 Aug; 82(8):641-6. PubMed ID: 17874572 [TBL] [Abstract][Full Text] [Related]
10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
11. Plasma pooling to expedite bioequivalence estimation of rifampicin in fixed dose combinations. Panchagnula R; Parmar J; Kaur JK; Singh I; Bhade SR Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):161-7. PubMed ID: 16810342 [TBL] [Abstract][Full Text] [Related]
12. In Vitro-In Vivo Evaluation of Novel Co-spray Dried Rifampicin Phospholipid Lipospheres for Oral Delivery. Singh C; Koduri LV; Bhatt TD; Jhamb SS; Mishra V; Gill MS; Suresh S AAPS PharmSciTech; 2017 Jan; 18(1):138-146. PubMed ID: 26902373 [TBL] [Abstract][Full Text] [Related]
13. Some plasma and saliva pharmacokinetics parameters of rifampicin in the presence of pefloxacin. Orisakwe OE; Akunyili DN; Agbasi PU; Ezejiofor NA Am J Ther; 2004; 11(4):283-7. PubMed ID: 15266220 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs. Garcia Contreras L; Sung J; Ibrahim M; Elbert K; Edwards D; Hickey A Mol Pharm; 2015 Aug; 12(8):2642-50. PubMed ID: 25942002 [TBL] [Abstract][Full Text] [Related]
15. Effects of Pluronic F68 and Labrasol on the intestinal absorption and pharmacokinetics of rifampicin in rats. Ma L; Wei Y; Zhou Y; Ma X; Wu X Arch Pharm Res; 2011 Nov; 34(11):1939-43. PubMed ID: 22139693 [TBL] [Abstract][Full Text] [Related]
16. Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects. Qurrat-ul-Ain ; Sharma S; Khuller GK; Garg SK J Antimicrob Chemother; 2003 Apr; 51(4):931-8. PubMed ID: 12654730 [TBL] [Abstract][Full Text] [Related]
17. Non-linear pharmacokinetics of rifampicin in healthy Asian Indian volunteers. Pargal A; Rani S Int J Tuberc Lung Dis; 2001 Jan; 5(1):70-9. PubMed ID: 11263520 [TBL] [Abstract][Full Text] [Related]
18. [Enhancement of rectal absorption of rifampicin by sodium para-aminosalicylate dihydrate in human subjects]. Suzuki R; Nakajima Y; Yagi N; Kenmotsu H; Sekikawa H; Miyazaki S; Mino K; Ohwada S; Kishi F; Hayashi N Yakugaku Zasshi; 1994 Nov; 114(11):894-900. PubMed ID: 7853151 [TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of oral rifampicin in AIDS patients. Jaruratanasirikul S J Med Assoc Thai; 1998 Jan; 81(1):25-8. PubMed ID: 9470318 [TBL] [Abstract][Full Text] [Related]
20. Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis. Hirota K; Hasegawa T; Nakajima T; Inagawa H; Kohchi C; Soma G; Makino K; Terada H J Control Release; 2010 Mar; 142(3):339-46. PubMed ID: 19951729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]